PE-Labeled Monoclonal Anti-Human CD19 Antibody, Mouse IgG2a (FMC63)

Monoclonal Anti-Human CD19 Antibody, Mouse IgG2a (FMC63) is a mouse monoclonal antibody recombinantly expressed from human 293 cells (HEK293), which provides higher batch consistency and long term security of supply.

Product Specifications

Background

FMC63 is an IgG2a mouse monoclonal antibody specific for CD19, which is a target for the immunotherapy of B lineage leukaemias and lymphomas. FMC63 scFv is the most commonly used ectodomain component of CD19-specific CARs. So far, most of reported CART19 trials contain the anti-CD19 scFv derived from FMC63, including the two FDA-approved CARs Kymriah and Yescarta.

CAS Number

9007-83-4

Host

HEK293

Origin Species

Mouse

Target

CD19

Conjugation

PE Labeled

Tag

Mouse IgG2a | Mouse Kappa

Applications

Flow Cytometry (Detection the expression of CD19 on Human cells) .

Stability

-20°C to -70°C for 24 months in lyophilized state; -70°C for 12 months after reconstitution. 2-8 °C for 12 months after reconstitution. For long term storage, the product should be stored at lyophilized state at -20°C or lower. Please protect from light and avoid repeated freeze-thaw cycles.